Entero Therapeutics's total assets for Q were $86.29M, a decrease of -5.32% from the previous quarter. ENTO total liabilities were $15.49M for the fiscal quarter, a 16.70% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.